Abstract

Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different outcomes related to their various adapted policies. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons. This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries. Using a deductive approach, data were extracted and analyzed based on the components of the WHO Building Blocks Framework. Finally, we compared the Iranian policies with the nine selected countries. Documents analysis revealed a spectrum of policies, which have led to a variety of outcomes. Based on our findings, three main strategies (widespread testing, comprehensive contact tracing, and timely measures) were the most effective directions to combat COVID-19. The experience of the first and second waves of COVID-19 showed that the risk of coronavirus is serious and will continue until a vaccine or decisive treatment is achieved. Therefore, countries are required to adopt appropriate and tailored policies to deal with this crisis effectively. Applying the experiences from the previous waves is essential for more efficient performance in the likely upcoming waves.

Highlights

  • On the last days of 2019, an unknown type of pneumonia was reported in Wuhan, Hubei province, China, which was later named as coronavirus disease 2019 (COVID-19).[1]

  • Ever since the outbreak was announced in China, the World Health Organization (WHO) has been at the center of global coordination for data analysis, advice provision and assisting countries for preparation in combating the pandemic[1], including regular reports on the epidemical situation of the disease and the COVID-19 Strategic Preparedness and Response Plan.[6]

  • Document analysis of the selected countries shows that they have been adopting different policies and measures in response to the COVID-19 crisis, which has led to different outcomes

Read more

Summary

Introduction

On the last days of 2019, an unknown type of pneumonia was reported in Wuhan, Hubei province, China, which was later named as coronavirus disease 2019 (COVID-19).[1]. Ever since the outbreak was announced in China, the WHO has been at the center of global coordination for data analysis, advice provision and assisting countries for preparation in combating the pandemic[1], including regular reports on the epidemical situation of the disease and the COVID-19 Strategic Preparedness and Response Plan.[6]. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons. Methods: This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.